Literature DB >> 21851433

Satisfaction and quality of life: a survey-based assessment in patients with a totally implantable venous port system.

S N Nagel1, U K M Teichgräber, S Kausche, A Lehmann.   

Abstract

The purpose was to assess the satisfaction and quality of life in patients with a totally implantable central venous port system using a questionnaire-based survey. A self-designed questionnaire to assess patient satisfaction and the impact of the port on daily life was dispatched 180 days after implantation. The questionnaire was combined with the commonly used short form (SF)-12 Health Survey quality of life questionnaire. Of the 98 patients who received a port system, 75 were contacted, and 42 (56%) returned the questionnaire. Most of the responding patients reported high overall satisfaction. The impact of the system on daily life was widely perceived not to be negative. The physical component summary (PCS) and the mental component summary (MCS) scores from the SF-12 were 35.5 and 45.23 respectively (general German population: PCS = 49.6, MCS = 52.3). The multiple stepwise regression showed that the cosmetic result was a predictor of overall satisfaction; the cosmetic result and a painful port together were predictors of the MCS. Overall, it was found that the cosmetic result of the implantation procedure was a predictor of satisfaction and quality of life and should thus not be underestimated.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21851433     DOI: 10.1111/j.1365-2354.2011.01275.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  7 in total

1.  Improving cancer patients' knowledge about totally implantable access port: a randomized controlled trial.

Authors:  Michela Piredda; Valentina Biagioli; Diana Giannarelli; Daniele Incletoli; Francesca Grieco; Massimiliano Carassiti; Maria Grazia De Marinis
Journal:  Support Care Cancer       Date:  2015-07-24       Impact factor: 3.603

2.  Retrospective outcome analysis of rates and types of complications after 8654 minimally invasive radiological port implantations via the subclavian vein without ultrasound guidance.

Authors:  Karolin J Paprottka; Jana Voelklein; Tobias Waggershauser; Maximilian F Reiser; Philipp M Paprottka
Journal:  Radiol Med       Date:  2019-06-07       Impact factor: 3.469

3.  Percutaneous image-guided implantation of totally implantable venous access ports in the forearm or the chest? A patients' point of view.

Authors:  Jan Peter Goltz; Bernhard Petritsch; Johannes Kirchner; Dietbert Hahn; Ralph Kickuth
Journal:  Support Care Cancer       Date:  2012-07-25       Impact factor: 3.603

4.  Palliative treatment of colorectal cancer in Germany: cost of care and quality of life.

Authors:  Martin Emmert; Katharina Pohl-Dernick; Axel Wein; Frank Dörje; Susanne Merkel; Frank Boxberger; Gudrun Männlein; Robert Joost; Hans-Detlev Harich; Roland Thiemann; Christof Lamberti; Markus F Neurath; Werner Hohenberger; Oliver Schöffski
Journal:  Eur J Health Econ       Date:  2012-06-12

5.  Wound Closure After Port Implantation-A Randomized Controlled Trial Comparing Tissue Adhesive and Intracutaneous Suturing.

Authors:  Saskia Witting; Maja Ingwersen; Thomas Lehmann; René Aschenbach; Niklas Eckardt; Jürgen Zanow; René Fahrner; Stephan Lotze; Reinhard Friedel; Mark Lenz; Claudia Schmidt; Diana Miguel; Laine Ludriksone; Ulf Teichgräber
Journal:  Dtsch Arztebl Int       Date:  2021-11-05       Impact factor: 8.251

6.  Patient acceptability of three different central venous access devices for the delivery of systemic anticancer therapy: a qualitative study.

Authors:  Caoimhe Ryan; Hannah Hesselgreaves; Olivia Wu; Jonathan Moss; James Paul; Judith Dixon-Hughes; Evi Germeni
Journal:  BMJ Open       Date:  2019-07-09       Impact factor: 2.692

7.  Risk factors for venous port migration in a single institute in Taiwan.

Authors:  Wen-Chieh Fan; Cheng-Han Wu; Ming-Ju Tsai; Ying-Ming Tsai; Hsu-Liang Chang; Jen-Yu Hung; Pei-Huan Chen; Chih-Jen Yang
Journal:  World J Surg Oncol       Date:  2014-01-14       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.